| Financial Year |
March 31 2023 |
| Monetary Funds |
1,351,964,010.18 |
| Held-for-trading Financial Assets |
68,126,400.00 |
| Notes Receivable |
303,453,056.11 |
| Accounts Receivable |
3,120,541,835.72 |
| Advances to Suppliers |
602,145,868.38 |
| Other Receivables |
315,902,327.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,041,431,696.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
77,120,664.76 |
| Total Current Assets |
7,958,000,436.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
409,219,941.72 |
| Long-term Equity Investment |
1,277,148,229.63 |
| Investment Properties |
109,055,432.36 |
| Fixed Assetes |
712,748,267.83 |
| Under-construction Projects |
34,735,648.25 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
578,377,237.36 |
| R&D expenses |
70,414,870.91 |
| Goodwill |
2,187,572,001.77 |
| Long-Term Deferred and Prepaid Expenses |
10,970,912.97 |
| Deferred Income Tax Assets |
89,927,427.02 |
| Other Non-Current Assets |
729,281,062.17 |
| Sub-Total of Non-Current Assets |
6,259,809,886.41 |
| Total Assets |
14,217,810,323.16 |
| Short-Term Loans |
489,940,972.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
567,534,110.44 |
| Accounts Payable |
1,305,365,479.26 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,324,163.96 |
| Taxes Payable |
74,713,273.67 |
| Interest Payable |
835,100.00 |
| Dividend Payable |
387,200.00 |
| Other payables |
651,370,618.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,148,343.56 |
| Other Current Liabilities |
54,444,759.66 |
| Sub-Total of Current Liabilities |
3,840,769,037.99 |
| Long-term Loans |
180,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
10,126,464.50 |
| Deferred Income Tax Liabilities |
34,068,700.56 |
| Other Non-Current Liabilities |
43,850,149.82 |
| Sub-Total of Non-Current Liabilities |
330,562,660.05 |
| Total Liabilities |
4,171,331,698.04 |
| Paid-In Capital(Or Share Stock) |
358,376,900.00 |
| Capital Surplus |
5,292,307,148.77 |
| Surplus Reserve |
49,361,498.48 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,081,328,713.29 |
| Minority Stockholder's Interest |
1,244,028,269.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,802,450,355.20 |
| Owner's Equity（Stockholder's Equity） |
10,046,478,625.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,217,810,323.16 |
